Cargando…

Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system

BACKGROUND: A critical step in access to genetic testing for hereditary cancer syndromes is referral for genetic counseling to assess personal and family risk. Individuals meeting testing guidelines have the greatest need to be evaluated. However, referrals to genetics are underutilized in US patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muessig, Kristin R., Zepp, Jamilyn M., Keast, Erin, Shuster, Elizabeth E., Reyes, Ana A., Arnold, Briana, Ingphakorn, Chalinya, Gilmore, Marian J., Kauffman, Tia L., Hunter, Jessica Ezzell, Knerr, Sarah, Feigelson, Heather S., Goddard, Katrina A. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832647/ https://www.ncbi.nlm.nih.gov/pubmed/35144679 http://dx.doi.org/10.1186/s13053-022-00213-5

Ejemplares similares

Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system
por: Crain, Philip R., et al.
Publicado: (2022)

Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study
por: Guo, Boya, et al.
Publicado: (2023)

Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study
por: Mittendorf, Kathleen F., et al.
Publicado: (2019)

Adaptation and early implementation of the PREdiction model for gene mutations (PREMM(5)™) for lynch syndrome risk assessment in a diverse population
por: Mittendorf, Kathleen F., et al.
Publicado: (2021)

Stakeholder perspectives on implementing a universal lynch syndrome screening program: A qualitative study of early barriers and facilitators
por: Schneider, Jennifer L, et al.
Publicado: (2015)

Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers
por: Hunter, Jessica Ezzell, et al.
Publicado: (2015)

Feasibility of a Traceback Approach for Using Pathology Specimens to Facilitate Genetic Testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study Protocol
por: Kauffman, Tia L., et al.
Publicado: (2021)

An Examination of the Ethical and Legal Limits in Implementing “Traceback Testing” for Deceased Patients
por: Martucci, Jessica, et al.
Publicado: (2022)

Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews
por: Mittendorf, Kathleen F., et al.
Publicado: (2022)

Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories
por: Feigelson, Heather Spencer, et al.
Publicado: (2012)

Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing
por: Himes, Patricia, et al.
Publicado: (2017)

Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy
por: Webber, Elizabeth M, et al.
Publicado: (2015)

Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome Sequencing
por: Lynch, Frances L., et al.
Publicado: (2018)

Establishing the Medical Actionability of Genomic Variants
por: Goddard, Katrina A.B., et al.
Publicado: (2022)

The NextGen Study: patient motivation for participation in genome sequencing for carrier status
por: Kauffman, Tia L., et al.
Publicado: (2017)

Evaluating cancer genetic services in a safety net system: overcoming barriers for a lasting impact beyond the CHARM research project
por: Okuyama, Sonia, et al.
Publicado: (2023)

Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening
por: Clarke, Elizabeth V., et al.
Publicado: (2018)

“Is It Worth Knowing?” Focus Group Participants’ Perceived Utility of Genomic Preconception Carrier Screening
por: Schneider, Jennifer L., et al.
Publicado: (2015)

Refining a Multifaceted Model of Perceived Utility of Genomic Sequencing Results
por: Duenas, Devan M., et al.
Publicado: (2023)

Assessing the implications of positive genomic screening results
por: Waltz, Margaret, et al.
Publicado: (2020)

A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation
por: Hunter, Jessica Ezzell, et al.
Publicado: (2016)

Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews
por: Schneider, Jennifer L., et al.
Publicado: (2018)

Does KRAS Testing in Metastatic Colorectal Cancer Impact Overall Survival? A Comparative Effectiveness Study in a Population-Based Sample
por: Feigelson, Heather Spencer, et al.
Publicado: (2014)

Returning negative results to individuals in a genomic screening program: Lessons learned
por: Butterfield, Rita M., et al.
Publicado: (2018)

Developing an Algorithm to Identify History of Cancer Using Electronic Medical Records
por: Clarke, Christina L., et al.
Publicado: (2016)

Future possibilities in the prevention of breast cancer: Role of genetic variation in breast cancer prevention
por: Feigelson, Heather Spencer, et al.
Publicado: (2000)

Ecallantide for the Treatment of Hereditary Angiodema in Adults
por: Lunn, Michael, et al.
Publicado: (2011)

Genes and Genetic Testing in Hereditary Ataxias
por: Sandford, Erin, et al.
Publicado: (2014)

Lessons learned about harmonizing survey measures for the CSER consortium
por: Goddard, Katrina A.B., et al.
Publicado: (2020)

Oncologists' attitudes toward KRAS testing: a multisite study
por: Harris, Julie N, et al.
Publicado: (2013)

XANTHINE OXIDASE ACTIVITY IN REGENERATING LIVER
por: Feigelson, Muriel, et al.
Publicado: (1957)

Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing
por: Kauffman, Tia L., et al.
Publicado: (2016)

Clustering of comorbid conditions among women who carry an FMR1 premutation
por: Allen, Emily Graves, et al.
Publicado: (2020)

Conducting clinical genomics research during the COVID‐19 pandemic: Lessons learned from the CSER consortium experience
por: Kraft, Stephanie A., et al.
Publicado: (2022)

Chronic Lymphocytic Leukemia as an Unusual Cause of Rapid Airway Compromise
por: Bersabe, Adrian R., et al.
Publicado: (2017)

mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model
por: Cacicedo, Maximiliano L., et al.
Publicado: (2022)

Programación de gráficos en Turbo C++ /
por: Ezzell, Ben
Publicado: (1993)

Graphics programming in Turbo C++
por: Ezzell, Ben
Publicado: (1990)

FASEB in Las Vegas
por: Ezzell, Carol
Publicado: (1988)

Spotlight on Israeli science products
por: Ezzell, Carol
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_gepr3d3a6930tumt39bk03cftt